Amberen

Los Angeles, United States Founded: 2007 • Age: 19 yrs
Menopause relief supplements are provided by Amberen for symptom management.
Annual revenue - Latest available
Total funding $2.0M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Amberen

Amberen is a company based in Los Angeles (United States) founded in 2007 by Roman Trunin. Amberen has raised $2 million across 1 funding round. Amberen operates in a competitive market with competitors including Gynoveda, Aptorum Group, DOMMA, MidwayBiome and NineB, among others.

  • Headquarter Los Angeles, United States
  • Founders Roman Trunin
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $2 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2 M (USD), Seed

    Oct 15, 2019

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Amberen

Amberen has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Amberen

Investments
Premium access

Investment portfolio details for Amberen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Amberen

Premium access

Detailed financials for Amberen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Amberen Comparisons

Amberen Primary company
Description
Menopause relief supplements are provided by Amberen for sym...
Location
Los Angeles, United States
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Amberen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Amberen

Amberen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynoveda, Aptorum Group, DOMMA, MidwayBiome and NineB, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Dietary supplements and Ayurvedic solutions for women's health are offered.
Locked Locked Locked
Developer of small molecular therapeutics for multiple disorders
Locked Locked Locked
Supplements and functional foods for women's menopause health are developed.
Locked Locked Locked
Developer of a proprietary daily dietary supplement to enhance bone health in post-menopausal women
Locked Locked Locked
Functional foods for women's health improvement are provided.
Premium access

Detailed competitors of Amberen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Amberen

Premium access

Complete news archive for Amberen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amberen

Amberen was founded in 2007 and raised its 1st funding round 12 years after it was founded.

Amberen is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

Roman Trunin is the current CEO of Amberen. They have also founded this company.

Amberen is a funded company, having raised a total of $2M across 1 funding round to date.

Amberen was established in 2007 in Los Angeles, United States, within the health supplement sector. Focus is placed on a menopause relief product formulated with ingredients including ammonium succinate, glycine, tocopheryl acetate, and calcium disodium succinate. Symptoms such as hot flashes, night sweats, mood swings, low energy, and weight gain are targeted for alleviation. Distribution occurs through online channels and retail partnerships across the United States.

Amberen's top competitors include Gynoveda, Aptorum Group and DOMMA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available